Clinical Trials Directory

Trials / Completed

CompletedNCT05824637

Validation and Reproducibility of S.P.A.T. With Allergens

Validation and Reproducibility of Type I Hypersensitivity Reaction in the Diagnostic Process of the Skin Prick Test in Allergic and Non-allergic Individuals

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
112 (actual)
Sponsor
Hippocreates · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

To improve accuracy and take out human error opportunities, Hippo Dx developed S.P.A.T., an automated skin prick test. This study will provide a comparison between manual and automated skin prick test in allergic and non-allergic individuals with a panel of common inhalant allergens. The primary endpoint is to compare the accuracy of S.P.A.T. to detect sensitization to common aeroallergens compared to a manual skin prick test (SPT). It is a prospective monocentric study that will include 120 study participants.

Conditions

Interventions

TypeNameDescription
DEVICESkin Prick Automated Testskin prick test to detection sensitisation to aeroallergens
DIAGNOSTIC_TESTSkin Prick Manual Testskin prick test to detection sensitisation to aeroallergens

Timeline

Start date
2023-03-18
Primary completion
2023-04-30
Completion
2023-06-30
First posted
2023-04-21
Last updated
2024-02-28

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT05824637. Inclusion in this directory is not an endorsement.

Validation and Reproducibility of S.P.A.T. With Allergens (NCT05824637) · Clinical Trials Directory